The application describes a population-based case-cohort study to determine whether retinal arteriolar changes (generalized narrowing, focal narrowing and arterio-venous nicking) and retinopathy are associated with 10-year stroke-and ischemic heart disease-related mortality. The study population will be selected from participants of the Beaver Dam Eye Study, a well-characterized population of predominantly white persons aged 43-86 years at the baseline examination in 1988-90. Cases are defined as participants who have died from either stroke or ischemic heart disease since the baseline examination. Three participants per case will be selected from the cohort at baseline as controls, matched on gender and 5-year age intervals to cases. Focal arteriolar narrowing, arteriovenous nicking and retinopathy have been graded to baseline using a standardized photographic grading protocol. To evaluate generalized arteriolar narrowing, a method modified from the Atherosclerosis Risk in Communities Study will be used. Retinal photographs will be digitized and processed using a high-resolution scanner. Retinal arteriole and venule widths will then be measured with the help of a computer program based on pixel density contrast between the vessel and the background retina. Finally, the average width of the arterioles will be summarized as a retinal arteriole to venule ratio (AVR). Standard case-control methodology will be applied to calculate the relative odds of association between generalized retinal arteriolar narrowing (using different categories of AVR) and other changes with stroke-and ischemic heart disease-related mortality. Logistic regression models controlling for potential confounders (e.g., blood pressure, serum lipid levels) will be employed to evaluate the independent association between retinal arteriolar characteristics and stroke- and ischemic heart disease mortality. Data from this study will improve the understanding of the association between microvascular characteristics and cardiovascular mortality.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL066018-02
Application #
6530750
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Olson, Jean
Project Start
2001-03-01
Project End
2003-02-28
Budget Start
2002-03-01
Budget End
2003-02-28
Support Year
2
Fiscal Year
2002
Total Cost
$72,750
Indirect Cost
Name
University of Wisconsin Madison
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Liew, Gerald; Campbell, Stephen; Klein, Ronald et al. (2011) Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study. Ophthalmology 118:1612-8
Wong, Tien Yin; Shankar, Anoop; Klein, Ronald et al. (2005) Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med 165:1060-5
Wong, Tien Yin; Knudtson, Michael D; Klein, Ronald et al. (2004) Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 111:1183-90
Knudtson, M D; Klein, B E K; Klein, R et al. (2004) Variation associated with measurement of retinal vessel diameters at different points in the pulse cycle. Br J Ophthalmol 88:57-61
Wong, Tien Yin; Knudtson, Michael D; Klein, Ronald et al. (2004) A prospective cohort study of retinal arteriolar narrowing and mortality. Am J Epidemiol 159:819-25
Wong, Tien Yin; Shankar, Anoop; Klein, Ronald et al. (2004) Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 329:79
Wong, Tien Yin; Klein, Ronald; Nieto, F Javier et al. (2003) Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology 110:933-40
Wong, Tien Yin; Klein, Ronald; Klein, Barbara E K et al. (2003) Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci 44:4644-50